We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sigma-Aldrich to Sell Diagnostics Business

By HospiMedica staff writers
Posted on 06 May 2002
Following declining sales in its diagnostics business coupled with a failure to meet expectations, Sigma-Aldrich Corp. More...
(St. Louis, MO, USA) has decided to discontinue this business. Certain items have been reclassified out of diagnostics and into the company's scientific research unit, but all remaining assets are for sale. The diagnostics business had sales of around US$65 million in 2001.

At the beginning of 2000, Sigma-Aldrich began to refocus the diagnostics business on niche opportunities, with a three-year plan to restore it contribution toward overall company targets of 10% growth in sales and profits. However, this growth never materialized and sales declined.

Just a month ago, Sigma-Aldrich announced the signing of a nonbinding letter of intent to sell its enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc. (Miami, FL, USA) for an undisclosed amount. This product line represented less than 10% of the diagnostic's business sales. Sigma-Aldrich supplies biochemical and organic chemical products and kits used in scientific and genomic research, biotechnology, pharmaceutical development, and chemical manufacturing. The company operates in 33 countries around the world.




Related Links:
Sigma-Aldrich
Ivax

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.